Ligand Pharmaceuticals reported $6.62M in Trade Creditors for its fourth fiscal quarter of 2020.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Trade Creditors Change
Acceleron Pharma XLRN:US $ 8.47M 0.39M
Amgen AMGN:US $ 1421M 260M
Arena Pharmaceuticals ARNA:US $ 12M 4.32M
Arrowhead Research ARWR:US $ 4.83M 2M
Bristol Myers Squibb BMY:US $ 2713M 272M
Clovis Oncology CLVS:US $ 26.69M 8.8M
Dicerna Pharmaceuticals DRNA:US $ 7.9M 0.65M
Eli Lilly And LLY:US $ 1606.7M 176.6M
Enanta Pharmaceuticals ENTA:US $ 6.3M 0.57M
Endo International Ordinary Shares ENDP:US $ 94.41M 10.21M
Gilead Sciences GILD:US $ 844M 317M
Harsco HSC:US $ 218.04M 12.91M
Heron Therapeutics HRTX:US $ 0.52M 11.54M
Immunogen IMGN:US $ 9.54M 0.62M
Insmed INSM:US $ 42.85M 20.71M
Karyopharm Therapeutics KPTI:US $ 4.45M 2.03M
Lannett LCI:US $ 42.67M 4.87M
Ligand Pharmaceuticals LGND:US $ 6.62M 3.55M
Macrogenics MGNX:US $ 8.03M 3.65M
Merk MRK:US $ 4594M 850M
Pacira Pharmaceuticals PCRX:US $ 10.43M 2.58M
Pfizer PFE:US $ 4309M 168M
Teva Pharmaceutical Industries TEVA:US $ 1756M 40M
Veracyte VCYT:US $ 3.12M 1.18M